Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Camille Jacques

12PUBLICATIONS
4CO-AUTHORS
Medical virologyEnvironmental epidemiologyMolecular targetsOenology and viticultureGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

Sort by Publication Date:
|Jun 26, 2026
In Vitro Effects of the Three Actives IL-12 (5 CH), IFN-γ (6 CH), and TNF-α (5 CH) from the Micro-Immunotherapy Medicine 2LEID-N<sup>®</sup> on Several Populations of Immune Cells.

|Jun 25, 2026
Perspective: Personalized Management of Oxidative and Nitrosative Stress in Post-Exercise Recovery with a Particular Emphasis on the Potential of Micro-Immunotherapy.

|May 14, 2025
Active Substances from the Micro-Immunotherapy Medicine 2LC1<sup>®</sup> Show In Vitro Anti-Cancer Properties in Colon, Prostate, and Breast Cancer Models and Immune-Enhancing Capabilities in Human Macrophages.

Camille Jacques, Irene Marchesi, Francesco Paolo Fiorentino

|Mar 26, 2025
Understanding the Mode of Action of Several Active Ingredients from the Micro-Immunotherapy Medicine 2LZONA<sup>®</sup>.

Camille Jacques, Flora Marchand, Mathias Chatelais

|Apr 13, 2024
The Micro-Immunotherapy Medicine 2LPAPI<sup>®</sup> Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells.

Camille Jacques, Flora Marchand, Mathias Chatelais

|Mar 28, 2024
In Vitro Study of Interleukin-6 when Used at Low Dose and Ultra-Low Dose in Micro-Immunotherapy.

Camille Jacques, Flora Marchand, Mathias Chatelais

Pageof 2

Frequent Collaborators

12 joint publications

Ilaria Floris

1 joint publications

Francesco Paolo Fiorentino

1 joint publications

Virginie Albinet

1 joint publications

Joana M Buades

Frequent Collaborators

12 joint publications

Ilaria Floris

1 joint publications

Francesco Paolo Fiorentino

1 joint publications

Virginie Albinet

1 joint publications

Joana M Buades